STUDIES OF HEMOPHILIA. II. THE ASSAY OF THE ANTIHEMOPHILIC CLOT-PROMOTING PRINCIPLE IN NORMAL HUMAN PLASMA WITH SOME OBSERVATIONS ON THE RELATIVE POTENCY OF CERTAIN PLASMA FRACTIONS 1
Open Access
- 1 January 1948
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 27 (1), 98-105
- https://doi.org/10.1172/jci101929
Abstract
The quantitative relationship between the coagulation time of shed hemophilic blood and the amt. of normal plasma added to it is described. Extremely minute amts. of normal plasma have a profound effect in accelerating the coagulation of hemophilic blood; as the amt. of normal plasma added is increased the increment in further reduction of the clotting time becomes less and less until the increment is no longer measurable. From the relationship it becomes apparent that in assaying the in vitro clot promoting activity of plasma or plasma protein fractions, the antihemophilic activity of 0.001 ml. of plasma should not be exceeded. The relationship provides a basis for assay of antihemophilic activity of biological materials, thus facilitating separation and purification of the antihemophilic component of normal plasma and study of its properties. Furthermore, the relationship was peculiar to, and constant in, each of 4 hemo-philics studied over a period of from 10 to 23 mo. It is proposed that normal plasma be considered a reference standard in studies aimed at concn. and purification of its antihemophilic clot promoting principle. One antihemophilic unit is defined as that amt. of antihemophilic material which accelerates the coagulation of 2 ml. of hemophilic blood to the same extent as 1 cmm. of avg. fresh citrated plasma. It was found that several samples of plasma protein Fraction I contained only 10-30% of the antihemophilic potency of whole plasma, whereas 100% of the activity was present in the fraction precipitable from diluted plasma by CO2.This publication has 12 references indexed in Scilit:
- CHEMICAL, CLINICAL AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. XXXIII. THE COAGULATION DEFECT IN HEMOPHILIA: THE EFFECT IN VITRO AND IN VIVO ON THE COAGULATION TIME IN HEMOPHILIA OF A PROTHROMBIN AND FIBRINOGEN-FREE NORMAL PLASMA AND ITS DERIVED PROTEIN FRACTIONS 123Journal of Clinical Investigation, 1946
- CHEMICAL, CLINICAL AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION: XXXII. THE COAGULATION DEFECT IN HEMOPHILIA. AN IN VITRO AND IN VIVO COMPARISON OF NORMAL AND HEMOPHILIC WHOLE BLOOD, PLASMA AND DERIVED PLASMA PROTEIN FRACTIONS 1Journal of Clinical Investigation, 1946
- THE COAGULATION DEFECT IN HEMOPHILIA: THE EFFECT, IN HEMOPHILIA, OF THE PARENTERAL ADMINISTRATION OF A FRACTION OF THE PLASMA GLOBULINS RICH IN FIBRINOGEN 123Journal of Clinical Investigation, 1945
- STUDIES IN BLOOD COAGULATION: THE COAGULATION PROPERTIES OF CERTAIN GLOBULIN FRACTIONS OF NORMAL HUMAN PLASMA IN VITRO12Journal of Clinical Investigation, 1945
- CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. I. THE CHARACTERIZATION OF THE PROTEIN FRACTIONS OF HUMAN PLASMA 12Journal of Clinical Investigation, 1944
- THE COAGULATION DEFECT IN HEMOPHILIA: STUDIES OF THE CLOT PROMOTING ACTIVITY ASSOCIATED WITH PLASMA EUGLOBULIN IN HEMOPHILIA 1Journal of Clinical Investigation, 1939
- THE COAGULATION DEFECT IN HEMOPHILIA. THE EFFECT IN HEMOPHILIA OF INTRAMUSCULAR ADMINISTRATION. OF A GLOBULIN SUBSTANCE DERIVED FROM NORMAL HUMAN PLASMA 1Journal of Clinical Investigation, 1937
- HEMOPHILIA. II. SOME PROPERTIES OF A SUBSTANCE OBTAINED FROM NORMAL HUMAN PLASMA EFFECTIVE IN ACCELERATING THE COAGULATION OF HEMOPHILIC BLOODJournal of Clinical Investigation, 1937
- HEMOPHILIA. I. THE ABNORMAL COAGULATION OF THE BLOOD AND ITS RELATION TO THE BLOOD PLATELETSJournal of Clinical Investigation, 1936
- STUDIES ON BLOOD COAGULATIONThe Journal of general physiology, 1935